SCPC Applauds Senate Judiciary Committee for Spotlighting PBM Anticompetitive Behavior, Urges Immediate Action on PBM Reform
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement thanking Senate Judiciary Chairman Chuck Grassley and members of the Committee for prioritizing pharmacy benefit manager (PBM) reform during today’s hearing, “PBM Power Play: Examining Competition Issues in the Prescription Drug Supply Chain.”
“PBMs have long exploited a broken and opaque drug pricing system, leveraging excessive markups and vertical integration to consolidate market power and boost profits to the detriment of patients and the LTC pharmacies that serve them. SCPC continues to urge Congress to pass legislation that immediately brings transparency and accountability to PBM practices.
“We applaud Chairman Grassley and the Committee for shedding light on the anticompetitive behavior of PBMs, which has allowed three dominant companies to dictate when, where, and how most Americans access their medications—and at what cost. At the same time, PBMs are imposing unfair contracts and unsustainable reimbursement rates on long-term care (LTC) pharmacies, which are already grappling with the looming threat of closures due to Medicare Part D price negotiations that take effect in January 2026.
“PBM reform is urgent. Without action, many nursing homes and other LTC facilities across the country will lose access to LTC pharmacies that provide essential, around-the-clock care to seniors and other vulnerable populations. Any PBM reform must include LTC-specific provisions to give CMS the authority to enforce fair contracts and transparent pricing. We call on Congress to build on the momentum of today’s hearing and pass comprehensive PBM reform that protects LTC patients and providers,” said Alan Rosenbloom, President and CEO of SCPC.
###
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.